{"name":"Sirius Therapeutics Co., Ltd.","slug":"sirius-therapeutics-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOVDBCVXpjcHczSUdfMmk2OGlkN2RaZ2p4Y1l5OXVFVlg5R2pjZ1Q0aHc1aGpJNG1vSkhMc3BscGR3bF9scjZ6eWZqWXBYSW02S215cXczcEZwcldBNXFfUm1pYXBPcGtSZU9Na1JENzAzakdoT3cta0tNYTgxOTVVYTlwTXBoRjJXalAtUFh2MHVYaXM1QThJS0VZMHZlb3dCSGcwRll1Zk9qSy13?oc=5","date":"2026-03-31","type":"trial","source":"富途牛牛","summary":"IPO News | Jingyin Pharmaceuticals Submits Updated IPO Filing to HKEX; Core Product SRSD107 Currently Undergoing Phase II Multi-Regional Clinical Trials in Europe and China - 富途牛牛","headline":"IPO News | Jingyin Pharmaceuticals Submits Updated IPO Filing to HKEX; Core Product SRSD107 Currently Undergoing Phase I","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPMU1Tdkc1X1R2T3U3UE1Sa1RaR0JHcERMR3dkcE0zbXlYWjJ2dEM2SnNsSVlQUmM1TG1maENsbjBneDNjLUs5Nmg5NW9IQTVmSUs5SnVuM0ZjMmYzaGRnSnI2dkMyVDUzT1VkYnhQS0lPYUdpSWp3Zk80ZUMyVzFJSTB1b3NsMzRnVGRBT1NTOWZYeXZaMEduaGRLQzFJRk43RG5xMVhTYXVlQ2NUZmpvTklKMmF2OFRBdW85NmM2MnJmdw?oc=5","date":"2026-02-27","type":"pipeline","source":"Caixin Global","summary":"In Depth: China’s Biotech Push Into Small Nucleic Acid Drugs Draws Global Pharma - Caixin Global","headline":"In Depth: China’s Biotech Push Into Small Nucleic Acid Drugs Draws Global Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOYk5HOVp0VEY4eVREUlpuZmZYREVlUHlUUXJORW1xV05EUnA0STctNl9KOXh6aXFIVXpJYk9ZZkl5aGx1b1d4b0JDQ2pjQmRtYTZGbjlmRF9jcXdjVWg2dTJwbDhrNjZ6UHF2QjRsaDZqMFpkSE9BMTllMGVCQ2lfT3FZc0V0aEFURkw5bm96RllpQUtVWkZoMA?oc=5","date":"2026-02-13","type":"earnings","source":"Finviz","summary":"CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates - Finviz","headline":"CRSP Posts Wider-Than-Expected Loss in Q4, Sales Miss Estimates","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQa1ExUGx6a21pZGZoRnd3cFBobXlDRTBpalliTE1xeFJrc0xuZkZGaWF6bFNvc1dKNDVLZ0tnbFVqZ0Q3bFBqRHFFMFBhSWlsVnJqT2tpWVZrUldJRnBqM3U0VS1UemVWUDdxWF9mSVNXdmpad3JpOXFxd1FTS3F3YkZTNkQ4REpXSXRUdDQ4dkd0dWlWT2hMdWl6QWtQYktQYUdwYlY2SnBtUXU3TmZtZi1nWDJjNVZTQnBnNXBweWc5VWRUcHVEVmVCdU5qREpZUEdz?oc=5","date":"2026-02-13","type":"pipeline","source":"Benzinga","summary":"Why Is CRISPR Therapeutics Stock Surging Friday? - CRISPR Therapeutics (NASDAQ:CRSP) - Benzinga","headline":"Why Is CRISPR Therapeutics Stock Surging Friday? - CRISPR Therapeutics (NASDAQ:CRSP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOajhrTmxrQXA2cDlGWkgxY1QyRVlzc1FFMEphQkEzX1hoWGw4cXY5M2ZQRTVBM1dqTHZwWnl2b21laFVPaHhkcG90c09COEFDNks0a0daaEh2UjBBVXNOeFQzVWxvdFhWQ3ZvT2dhaW5pWFdNTnJESHFpc1ZSbTBrbTMtSGRnenBhdlNvWnYtLXJGTGFxLWVzVG9Jd2VqWXVWNEE?oc=5","date":"2026-02-12","type":"pipeline","source":"TradingView","summary":"CRISPR Therapeutics AG SEC 10-K Report - TradingView","headline":"CRISPR Therapeutics AG SEC 10-K Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQcW1UdV8wbGtwTTlScHRfUk1EYW1GVFNiWDdjSjhXYlBsc1hlOEpZMUg2LXN0aDN5dmpjbFRyTDJVWmMzWGExdmw5WDhPVWJOQUluSlBJTkFPOUl2TEM0ak9qd3F3Znd2ZE15XzVBNWMzSkJuYjczeUJhR2NUaVd6NE9XWnFhcU1heGszaGJNT0I1MW5YcmJ6cWZCRUh0WTZneGJaUHZraTQxaTg5ODVsNDZrVWVxQlpBOURoY1ZXWmYyRVZQUFNNSGZRWFBtal9tM0FWYmlKYnVjQUViSktMaF91X0t6YzVtS3hoRERJVXl2TnNWOEFWQkZDQWcxZjg1SGlRTmQzMjNmd3VM?oc=5","date":"2026-02-12","type":"earnings","source":"GlobeNewswire","summary":"CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire","headline":"CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOQkQ0UGJONndVQjYwdmZvTThrUmJweE5oMG5oRklvQ2ltalRsX0xsY25McHVwb19HU2lPXzk3U0JGZ0RJN2ZFOHZoMEhERjMzckRETzNISTFJTVdqMHdGQ3lNLVhQTVpYb0tfV3hwVjRVTlBlM1M5SWlkV1U3Ym1xY1QyaWpSQQ?oc=5","date":"2025-12-12","type":"deal","source":"Finviz","summary":"2 Healthcare Stocks to Buy Ahead of the New Year - Finviz","headline":"2 Healthcare Stocks to Buy Ahead of the New Year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPeTJiY0tiOGRETEVpR2l5ODl6YTZBeTlNVzFseThOUGw4bmZYbG0wYkxaRUxGVUlKMjhJak90OFA2eS02bmEtQ285YWJQeWh1UEFnYTAyWU5PUjZOeWlvdzA2SUZ4MS1HRDhEREtZUjA1QnhwdV9GM0c4c2JhRnZZaWZPWHp5bGFEaVZGOTJvLVZKX0dwdUVmOTJrNEd6ZVl0TVF0UWVhRmdCX2FUT0lndUlOLTI1M2dqUXpJLQ?oc=5","date":"2025-12-04","type":"deal","source":"Seeking Alpha","summary":"Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP) - Seeking Alpha","headline":"Cathie Wood’s Buys And Rumors Aside, Here’s Why Crispr Therapeutics Is A Strong Buy (CRSP)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOOVdOX1BibGRsUC1ncnQ5U1o1bEgzTUpiWUxjN2VrSjNqS2JSMEMtZ2d4Qlp3QkNKdXRDT1ZFS21oTUJBcTU3WW8tVGd2TDQydFRrRmo0NnNqTUhtZUJSTWhtQlZUdDJBenN0MlhmbEt0RUtZUWRtTC1zVk4zZ09naHNfWGxhd0JvMXM0MldR?oc=5","date":"2025-09-23","type":"trial","source":"Yahoo Finance","summary":"CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU - Yahoo Finance","headline":"CRSP & Sirius Begin Dosing in Thromboembolic Disorder Study in EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxNM2d1RktIUGFZMVQwazZySGo4VkFYc2ZRYmxxekJtUmRQblNvTndFWHRaYkN6bVE1X2pkRndGZUI1TThzb0M2OUJKc2s4bkgyZWc5U2JMeTFXS3RUNk1iNVU2bklFdnU3YWVtQzJubU5pVjdoVk1PbktGbHpJY1ZKZjhzbTVkcTl1OWhYRXZfRjFNT2MzQ2JaazhiM2VGZzJodkw0Tm1mc1pWQWhidmFrMUQ4Nk9Ya1VjeGhubGNBcU1oNDJmZXVQOWdyX2s4aW8wXzRWTERhWkRtTzlnRHV4d19keDQxZVh6cjhRVUFvZHg5RjN1ay1CTHZLdV9nOXFKbWVpd3hRWTBQN0RaZUJQMFRn?oc=5","date":"2025-05-19","type":"deal","source":"GlobeNewswire","summary":"CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies - GlobeNewswire","headline":"CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPRzA2MlREMFJKM2NRWEpNX2JsN3FmOFZzQ0dVT3VLaWZsRlBrR1hubDAta2htZkd1aElxbHpva0hJUVJadUt3NXhUT0FDYUlfb1pva0JSeF80UXJPMEpidHRlajBRbFUzR1VnMURRNkVoZFctMExkeHVNMXFBVFNNNF9RQzBjNV9sdW0yVjQ5UlgyOWFNWEF2aFhSaGhfZy1TcEE?oc=5","date":"2025-05-12","type":"pipeline","source":"BioWorld News","summary":"Sirius bags $50M series B2 for cardiovascular siRNA pipeline - BioWorld News","headline":"Sirius bags $50M series B2 for cardiovascular siRNA pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxPNUFIN0tSZi1pNHVYbmxsQ24zT0h4XzJUTERuMmpXMmM0eWpaSGsyMzFZWFdPbV83cWdQOHhYV3Z0dXg4WjBDTENVSE5YOTNDai1wb0xEYnUxaDBhVGJGbFgzcXRMdEJlV0Y2ZGJxVWVHRHZZSzZ2aHBqaENqR3hoRXhqWWo2Y25GQVJHek85dWxuMVlzazRxTHE5blY5blQ5bGV4LXEzMnE5Wi1OMTBfSkt6clNYUUplbF93LXpJZ0sydmMyQV92Nmt3WmxUa0pyM094UGZ2TXRyc3U5SkxvUnozZnRNb095ZV82V05BV2hhcEZFTm1pUFRwNmlYMjdUaXd4eGhkUG40VzFQZUZfanh4c0liMUtrR1NaY0FiQUE3dE1QdHI0RXZkTQ?oc=5","date":"2025-05-09","type":"pipeline","source":"Business Wire","summary":"Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for Cardiometabolic Diseases - Business Wire","headline":"Sirius Therapeutics Announces Nearly $50 Million Financing to Accelerate Clinical Development of siRNA Therapeutics for ","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}